Prologue Medicines
Prologue
Cambridge, United States · Founded 2021 · $50.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- prologuemedicines.com
- Total Funding
- $50.0M
- Last Round
- $50.0M Series AMay 2024
- Rounds
- 1
About
Flagship Pioneering biotech exploring the viral proteome using machine learning to discover transformative medicines.
Summary
Prologue Medicines is a Biotech company based in Cambridge, United States, founded in 2021. It has raised $50.0M in total across 1 round, most recently a $50.0M Series A round in May 2024. Investors include Flagship Pioneering.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2024
Investors
Similar Companies
China's leading blood products manufacturer

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...

Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/prologue-medicines"><img src="https://indexed.vc/api/badge/company/prologue-medicines" alt="Prologue Medicines on Indexed.vc" width="260" height="76" /></a>
